Comerica Securities’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$409K Sell
3,022
-132
-4% -$18K 0.03% 307
2023
Q2
$451K Sell
3,154
-209
-6% -$30.8K 0.03% 314
2023
Q1
$467K Buy
3,363
+525
+18% +$70.6K 0.03% 307
2022
Q4
$385K Buy
2,838
+138
+5% +$17.3K 0.03% 340
2022
Q3
$296K Buy
2,700
+819
+44% +$104K 0.02% 347
2022
Q2
$249K Sell
1,881
-896
-32% -$118K 0.02% 408
2022
Q1
$368K Sell
2,777
-116
-4% -$13.9K 0.02% 366
2021
Q4
$337K Buy
2,893
+116
+4% +$13.6K 0.02% 397
2021
Q3
$334K Sell
2,777
-58
-2% -$6.75K 0.02% 386
2021
Q2
$340K Sell
2,835
-283
-9% -$31K 0.03% 380
2021
Q1
$310K Buy
+3,118
New +$313K 0.02% 403
2020
Q4
Sell
-2,545
Closed -$279K 479
2020
Q3
$279K Sell
2,545
-133
-5% -$14.8K 0.02% 355
2020
Q2
$283K Sell
2,678
-147
-5% -$15.2K 0.03% 349
2020
Q1
$252K Sell
2,825
-710
-20% -$66.8K 0.03% 344
2019
Q4
$353K Sell
3,535
-96
-3% -$9.04K 0.03% 331
2019
Q3
$324K Buy
3,631
+579
+19% +$50.2K 0.03% 333
2019
Q2
$252K Buy
3,052
+288
+10% +$22.6K 0.03% 370
2019
Q1
$223K Sell
2,764
-1,043
-27% -$82.2K 0.03% 392
2018
Q4
$289K Sell
3,807
-977
-20% -$76.3K 0.04% 322
2018
Q3
$379K Sell
4,784
-2,762
-37% -$209K 0.04% 316
2018
Q2
$530K Sell
7,546
-590
-7% -$42.4K 0.06% 261
2018
Q1
$569K Sell
8,136
-1,291
-14% -$89.4K 0.07% 251
2017
Q4
$654K Buy
9,427
+774
+9% +$52.2K 0.08% 239
2017
Q3
$586K Buy
8,653
+1,468
+20% +$92.7K 0.08% 235
2017
Q2
$490K Buy
7,185
+1,341
+23% +$87.6K 0.07% 253
2017
Q1
$364K Buy
+5,844
New +$340K 0.06% 287
2016
Q4
Sell
-3,147
Closed -$207K 236
2016
Q3
$207K Buy
+3,147
New +$206K 0.09% 202

Other funds holding AZN